IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v40y2017i11d10.1007_s40264-017-0558-6.html
   My bibliography  Save this article

Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review

Author

Listed:
  • Yuan Luo

    (Northwestern University Feinberg School of Medicine)

  • William K. Thompson

    (Northwestern University Feinberg School of Medicine)

  • Timothy M. Herr

    (Northwestern University Feinberg School of Medicine)

  • Zexian Zeng

    (Northwestern University Feinberg School of Medicine)

  • Mark A. Berendsen

    (Galter Health Sciences Library, Northwestern University Feinberg School of Medicine)

  • Siddhartha R. Jonnalagadda

    (Northwestern University Feinberg School of Medicine
    Knowledge and Conversation Group, Microsoft)

  • Matthew B. Carson

    (Northwestern University Feinberg School of Medicine)

  • Justin Starren

    (Northwestern University Feinberg School of Medicine)

Abstract

The goal of pharmacovigilance is to detect, monitor, characterize and prevent adverse drug events (ADEs) with pharmaceutical products. This article is a comprehensive structured review of recent advances in applying natural language processing (NLP) to electronic health record (EHR) narratives for pharmacovigilance. We review methods of varying complexity and problem focus, summarize the current state-of-the-art in methodology advancement, discuss limitations and point out several promising future directions. The ability to accurately capture both semantic and syntactic structures in clinical narratives becomes increasingly critical to enable efficient and accurate ADE detection. Significant progress has been made in algorithm development and resource construction since 2000. Since 2012, statistical analysis and machine learning methods have gained traction in automation of ADE mining from EHR narratives. Current state-of-the-art methods for NLP-based ADE detection from EHRs show promise regarding their integration into production pharmacovigilance systems. In addition, integrating multifaceted, heterogeneous data sources has shown promise in improving ADE detection and has become increasingly adopted. On the other hand, challenges and opportunities remain across the frontier of NLP application to EHR-based pharmacovigilance, including proper characterization of ADE context, differentiation between off- and on-label drug-use ADEs, recognition of the importance of polypharmacy-induced ADEs, better integration of heterogeneous data sources, creation of shared corpora, and organization of shared-task challenges to advance the state-of-the-art.

Suggested Citation

  • Yuan Luo & William K. Thompson & Timothy M. Herr & Zexian Zeng & Mark A. Berendsen & Siddhartha R. Jonnalagadda & Matthew B. Carson & Justin Starren, 2017. "Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review," Drug Safety, Springer, vol. 40(11), pages 1075-1089, November.
  • Handle: RePEc:spr:drugsa:v:40:y:2017:i:11:d:10.1007_s40264-017-0558-6
    DOI: 10.1007/s40264-017-0558-6
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-017-0558-6
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s40264-017-0558-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Juan M. Banda & Alison Callahan & Rainer Winnenburg & Howard R. Strasberg & Aurel Cami & Ben Y. Reis & Santiago Vilar & George Hripcsak & Michel Dumontier & Nigam Haresh Shah, 2016. "Feasibility of Prioritizing Drug–Drug-Event Associations Found in Electronic Health Records," Drug Safety, Springer, vol. 39(1), pages 45-57, January.
    2. Rave Harpaz & Alison Callahan & Suzanne Tamang & Yen Low & David Odgers & Sam Finlayson & Kenneth Jung & Paea LePendu & Nigam Shah, 2014. "Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art," Drug Safety, Springer, vol. 37(10), pages 777-790, October.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Gianluca Trifirò & Janet Sultana & Andrew Bate, 2018. "From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources," Drug Safety, Springer, vol. 41(2), pages 143-149, February.
    2. Rybinski, Krzysztof, 2021. "Ranking professional forecasters by the predictive power of their narratives," International Journal of Forecasting, Elsevier, vol. 37(1), pages 186-204.
    3. Rybinski, Krzysztof, 2020. "The forecasting power of the multi-language narrative of sell-side research: A machine learning evaluation," Finance Research Letters, Elsevier, vol. 34(C).
    4. Yiqing Zhao & Yue Yu & Hanyin Wang & Yikuan Li & Yu Deng & Guoqian Jiang & Yuan Luo, 2022. "Machine Learning in Causal Inference: Application in Pharmacovigilance," Drug Safety, Springer, vol. 45(5), pages 459-476, May.
    5. Doris Chenguang Wu & Shiteng Zhong & Richard T R Qiu & Ji Wu, 2022. "Are customer reviews just reviews? Hotel forecasting using sentiment analysis," Tourism Economics, , vol. 28(3), pages 795-816, May.
    6. Tavpritesh Sethi & Nigam H. Shah, 2017. "Pharmacovigilance Using Textual Data: The Need to Go Deeper and Wider into the Con(text)," Drug Safety, Springer, vol. 40(11), pages 1047-1048, November.
    7. Na Zhang & Ping Yu & Yupeng Li & Wei Gao, 2022. "Research on the Evolution of Consumers’ Purchase Intention Based on Online Reviews and Opinion Dynamics," Sustainability, MDPI, vol. 14(24), pages 1-26, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Yiqing Zhao & Yue Yu & Hanyin Wang & Yikuan Li & Yu Deng & Guoqian Jiang & Yuan Luo, 2022. "Machine Learning in Causal Inference: Application in Pharmacovigilance," Drug Safety, Springer, vol. 45(5), pages 459-476, May.
    2. Eyal Eckhaus & Zachary Sheaffer, 2018. "Managerial hubris detection: the case of Enron," Risk Management, Palgrave Macmillan, vol. 20(4), pages 304-325, November.
    3. Lucie M. Gattepaille & Sara Hedfors Vidlin & Tomas Bergvall & Carrie E. Pierce & Johan Ellenius, 2020. "Prospective Evaluation of Adverse Event Recognition Systems in Twitter: Results from the Web-RADR Project," Drug Safety, Springer, vol. 43(8), pages 797-808, August.
    4. Tavpritesh Sethi & Nigam H. Shah, 2017. "Pharmacovigilance Using Textual Data: The Need to Go Deeper and Wider into the Con(text)," Drug Safety, Springer, vol. 40(11), pages 1047-1048, November.
    5. Susan Colilla & Elad Yom Tov & Ling Zhang & Marie-Laure Kurzinger & Stephanie Tcherny-Lessenot & Catherine Penfornis & Shang Jen & Danny S. Gonzalez & Patrick Caubel & Susan Welsh & Juhaeri Juhaeri, 2017. "Validation of New Signal Detection Methods for Web Query Log Data Compared to Signal Detection Algorithms Used With FAERS," Drug Safety, Springer, vol. 40(5), pages 399-408, May.
    6. Galit Klein & Eyal Eckhaus, 2017. "Sensemaking and sensegiving as predicting organizational crisis," Risk Management, Palgrave Macmillan, vol. 19(3), pages 225-244, August.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:40:y:2017:i:11:d:10.1007_s40264-017-0558-6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.